If symptoms do not improve over several weeks or worsen after stopping semaglutide, further investigation and gastroenterology referral may be warranted to consider alternative diagnoses
Patients commonly report early improvements in hunger management, followed by steady reductions in portion sizes, increased satisfaction with meals, and greater ease avoiding high calorie or sugary foods
Specifically, the FDA has approved semaglutide for adults who are clinically obese (BMI of 30 or higher) or overweight (BMI of 27 or higher) when accompanied by at least one weight-related health condition, such as hypertension, hyperlipidemia, cardiovascular disease, prediabetes, or obstructive sleep apnea
In addition to direct lipolytic potential, Frag 176-191 might indirectly support energy expenditure, possibly through potential modulation of 3-adrenergic receptor (3-AR) expression
Managing Patient Expectations and Business Risk One critical consideration for Med Spa owners is patient satisfaction
Metoclopramide can actually help your stomach empty faster